Scholars@Duke publication: Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment

construction release_alert

Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.

cancel

Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment

Publication , Journal Article

Dahm, P; Moul, JW

Published in: Oncology Report

September 1, 2005

Duke Scholars

Author Judd Wendell Moul Urology

Published In

Oncology Report

EISSN

1548-5323

ISSN

1548-5323

Publication Date

September 1, 2005

Issue

FALL

Start / End Page

64

Related Subject Headings

Oncology & Carcinogenesis

Citation

APA

Chicago

ICMJE

MLA

NLM

Dahm, P., & Moul, J. W. (2005). Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment. Oncology Report, (FALL), 64.

Dahm, P., and J. W. Moul. “Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment.” Oncology Report, no. FALL (September 1, 2005): 64.

Dahm P, Moul JW. Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment. Oncology Report. 2005 Sep 1;(FALL):64.

Dahm, P., and J. W. Moul. “Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment.” Oncology Report, no. FALL, Sept. 2005, p. 64.

Dahm P, Moul JW. Cytokine therapy not recommended for metastatic RCC of intermediate prognosis. Comment. Oncology Report. 2005 Sep 1;(FALL):64.

Published In

Oncology Report

EISSN

1548-5323

ISSN

1548-5323

Publication Date

September 1, 2005

Issue

FALL

Start / End Page

64

Related Subject Headings

Oncology & Carcinogenesis